Trevor, a 34-year-old software engineer in Sacramento, had been on bupropion for treatment-resistant depression for nine months when he was found unresponsive at his desk by a coworker who initially thought he was sleeping. The convulsions started while paramedics were loading him into the ambulance and continued through the emergency department triage area, prompting immediate intravenous lorazepam followed by a levetiracetam load when seizure activity persisted past five minutes. Total seizure time before pharmacological control was approximately fourteen minutes. EEG monitoring in the ICU showed continued nonconvulsive epileptiform activity for another six hours that responded to phenytoin escalation. When Trevor woke clearly two days later, he had no memory of the previous week, was profoundly depressed, and within 48 hours of discharge made a serious suicide attempt that his sister discovered in time to save him. The post-status mental health window had been completely overlooked in discharge planning, and Trevor’s experience became the case his neurology and psychiatry departments now use to teach residents about the suicide risk that follows status epilepticus.
Trevor’s story sits at the intersection of two specialties that often fail to coordinate: neurology and psychiatry. The relationship between status epilepticus mental health and psychiatric care matters because seizure-threshold-lowering medications are common in psychiatric practice, because post-ictal psychiatric syndromes are common and dangerous, and because the period after status epilepticus carries one of the highest short-term suicide risks documented in clinical literature. Status epilepticus is defined under current International League Against Epilepsy criteria as a seizure lasting five minutes or longer, or two or more seizures without recovery of consciousness between them. The five-minute threshold replaced the older thirty-minute definition because longer seizures cause more lasting neuronal injury and because pharmacological intervention must be initiated long before thirty minutes elapse.
Status epilepticus: definition and clinical significance
The contemporary definition of status epilepticus reflects two operational thresholds. T1, set at five minutes, marks the time when continuous seizure activity becomes unlikely to self-terminate and pharmacological intervention should begin. T2, set at thirty minutes, marks the time after which lasting consequences including neuronal injury, neurologic deficit, and death become significantly more likely. Convulsive status presents with sustained generalized tonic-clonic activity, while nonconvulsive status presents more subtly with altered consciousness, automatisms, or unresponsiveness, and requires EEG for diagnosis. Mortality in adult convulsive status epilepticus runs 15 to 20 percent in the modern era, with higher rates in older patients, those with anoxic precipitants, and refractory cases requiring prolonged sedation. Catatonia can occasionally be confused with nonconvulsive status epilepticus on initial presentation.
Psychiatric medications that lower seizure threshold
Several commonly prescribed psychotropic medications carry meaningful seizure risk that becomes clinically relevant in patients with epilepsy, alcohol or sedative withdrawal, brain injury, or other vulnerabilities. Bupropion, particularly the immediate-release formulation and at higher doses, has the highest seizure incidence among modern antidepressants, with rates approaching 0.4 percent at standard doses and rising sharply with overdose, eating disorders, or comorbid stimulant use. Clozapine carries dose-dependent seizure risk approaching 4 percent at doses above 600 milligrams per day. Tricyclic antidepressants, particularly clomipramine and amoxapine, lower threshold significantly, especially in overdose. Tramadol, often prescribed for pain in psychiatric patients, also reduces threshold. The U.S. Food and Drug Administration’s drug labeling resources document specific seizure warnings for these agents.
- Bupropion (especially IR; avoid in eating disorders, alcohol withdrawal, head injury)
- Clozapine (dose-dependent; consider prophylactic anticonvulsant above 600 mg/day)
- Tricyclic antidepressants (clomipramine and amoxapine highest risk)
- Tramadol and tapentadol
- Theophylline, lithium toxicity, and high-dose stimulants
- Maprotiline, chlorpromazine at high doses
- Withdrawal from benzodiazepines, alcohol, and barbiturates
Post-ictal psychosis: recognition and treatment
Post-ictal psychosis is a recognizable syndrome that develops within 24 to 72 hours after a flurry of seizures or status epilepticus, after a characteristic lucid interval during which the patient appears to recover. Symptoms include paranoia, hallucinations (often religious or grandiose), agitation, and mood lability, typically lasting days to weeks before remission. The lucid interval distinguishes it from peri-ictal confusion, which begins immediately after seizure activity. Suicide risk during post-ictal psychosis is substantial, and the syndrome can produce dangerous behavior including violence and impulsive self-harm. Treatment involves brief antipsychotic therapy, often with a second-generation agent at modest doses, alongside optimized seizure control. Most episodes resolve completely within two to three weeks, but recurrent episodes raise the lifetime risk of chronic interictal psychotic disorder and warrant longer-term psychiatric follow-up.
Post-ictal depression and the suicide risk window
Post-ictal depression is more common than post-ictal psychosis but receives substantially less clinical attention. Up to half of patients with epilepsy experience post-ictal depressive symptoms in the days following seizures, and these symptoms are an independent suicide risk factor. The week to month following hospitalization for status epilepticus carries one of the highest documented short-term suicide risks in any neurologic or psychiatric population, with risk elevated three- to fivefold compared to baseline epilepsy populations. The combination of a frightening medical event, post-ictal mood disturbance, post-traumatic distress related to the hospitalization, anticonvulsant medication side effects (some of which carry their own depression risk), and disruption of life roles all contribute. Discharge planning that ignores mental health, as in Trevor’s case, frequently misses the highest-risk window. Lithium toxicity can produce both seizures and depression and shares some discharge planning concerns.
Emergency department management of status epilepticus
Initial pharmacological treatment uses intravenous benzodiazepines as first-line therapy: lorazepam 4 milligrams IV (or 0.1 mg/kg), diazepam 10 milligrams IV, or midazolam 10 milligrams intramuscularly when IV access is delayed. The Established Status Epilepticus Treatment Trial demonstrated that levetiracetam, fosphenytoin, and valproic acid are equivalently effective as second-line agents after benzodiazepine failure. Refractory status, defined as continued seizure activity after first- and second-line therapy, requires intubation and continuous infusion of midazolam, propofol, or pentobarbital with continuous EEG monitoring in a neurocritical care setting. Super-refractory status, persistent or recurrent seizure activity after 24 hours of anesthetic infusion, may require ketamine, hypothermia, or immunotherapy in selected cases. The National Institute of Neurological Disorders and Stroke at ninds.nih.gov maintains current treatment guidelines.
Neurocritical care indications and ICU management
Patients with refractory status, those requiring continuous anesthetic infusions, and those with concerning underlying etiologies including traumatic brain injury, anoxic injury, autoimmune encephalitis, or central nervous system infection all benefit from neurocritical care unit admission. Continuous EEG monitoring detects nonconvulsive status that pharmacological paralysis can mask. Imaging including CT and often MRI evaluates structural causes. CSF analysis, autoimmune encephalitis panels, and toxicology screening identify reversible precipitants. The withdrawal of anesthetic infusions is a careful staged process with EEG correlation, and many patients require continued anticonvulsant therapy after discharge regardless of underlying epilepsy history. Coordination between neurology, critical care, and psychiatry during admission shapes the trajectory of post-discharge mental health.
Mental health follow-up after status epilepticus discharge
Discharge planning after status epilepticus should include scheduled mental health follow-up within seven to fourteen days, depression and suicide screening at every neurology visit during the first three months, family education about warning signs, and clear plans for medication adjustments if antidepressants or other psychotropics are part of the regimen. For patients whose status was precipitated by bupropion, clozapine, or other psychiatric medications, the question of how to manage underlying depression or psychotic illness without these agents demands close psychiatry-neurology collaboration. Alternative antidepressants with lower seizure profiles include sertraline, escitalopram, and mirtazapine. Alternative antipsychotics with lower seizure risk than clozapine include risperidone and aripiprazole. Alcohol withdrawal seizures share many features with status epilepticus and require similar coordinated post-discharge planning.
Frequently asked questions about status epilepticus and mental health
Can I take bupropion if I have well-controlled epilepsy?
Generally not as first-line treatment. Sertraline, escitalopram, and venlafaxine carry lower seizure risk and are typically preferred. If bupropion is considered, it requires neurology coordination and dose limitation.
How long does post-ictal psychosis last?
Most episodes resolve within one to three weeks with brief antipsychotic therapy and seizure control. Recurrent episodes raise risk of chronic interictal psychosis and warrant ongoing psychiatric care.
Why is suicide risk elevated after status epilepticus?
The combination of post-ictal depression, post-traumatic distress, anticonvulsant side effects, life disruption, and the medical event itself produces a window of elevated risk that extends weeks to months after discharge.
Will I need anticonvulsants forever after one episode of status?
Decision depends on underlying cause. Status from a reversible precipitant (medication overdose, withdrawal, infection) may not require long-term therapy. Status from underlying epilepsy or structural brain disease typically warrants continued anticonvulsant therapy.
Can clozapine be restarted after a seizure?
Sometimes, with concurrent anticonvulsant prophylaxis (typically valproate or lamotrigine) and dose reduction. The decision involves balancing seizure risk against the unique efficacy of clozapine in treatment-resistant illness, requiring psychiatry-neurology collaboration.
The bottom line
Status epilepticus is a neurological emergency with substantial mental health implications that extend well beyond the acute hospitalization. Psychiatric medications including bupropion, clozapine, and tricyclics can precipitate seizures in vulnerable patients. Post-ictal psychosis and post-ictal depression are common, sometimes severe, and carry meaningful suicide risk. Discharge planning must include mental health follow-up, suicide screening, and coordinated medication management between neurology and psychiatry. The National Institutes of Health at nih.gov publishes patient resources on epilepsy and mental health that families can use during the high-risk post-discharge window.
If you are in crisis or experiencing thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline, available twenty-four hours a day across the United States.
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified neurologist, psychiatrist, or emergency physician regarding seizure management, anticonvulsant therapy, and psychiatric medication decisions in patients with epilepsy or seizure history.